| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |